5874316024C Display Image
5874316024C Display Image

EfferSan Effervescent Tablets Qty 24

Code: 5874316024C D2-231

Application

EfferSan Tablets are used for research and development purposes such as biochemical research/analysis or for application as an analytical reagent.

F...


read more

Your Price
€133.97 EACH
€164.78 inc. VAT

Application

EfferSan Tablets are used for research and development purposes such as biochemical research/analysis or for application as an analytical reagent.

Features and Benefits

Prevents bacterial proliferation and biofilm formation to preserve RO membrane performance (ionic rejection, water recovery).

General description

EfferSan Effervescent Tablets (CA) are chlorine tablets used in filtration devices such as water purification systems and cartridges. This product optimally protects reverse osmosis (RO) membranes from fouling contaminants.

Legal Information

RIOS is a trademark of Millipore Corporation

ELIX is a registered trademark of Merck KGaA, Darmstadt, Germany

Milli-Q is a registered trademark of Merck KGaA, Darmstadt, Germany

AFS is a registered trademark of Merck KGaA, Darmstadt, Germany

availabilityavailable only in Canada
compatibilityfor use with Elix® Reference, for use with Milli-Q® IQ 7003, for use with AFS®, for use with Milli-Q® IQ 7010, for use with Milli-Q® HX, for use with RiOs Essential, for use with Milli-Q® IQ 7015, for use with Milli-Q® EQ 7016, for use with Milli-Q® IX 7010, for use with Milli-Q® HR, for use with Milli-Q® IX 7005, for use with Milli-Q® IQ 7005, for use with Milli-Q® EQ 7008, for use with Milli-Q® IX 7015, for use with Elix® Advantage, for use with Elix® Essential UV, for use with Milli-Q® IX 7003, for use with Elix® Essential
composition(mixture of troclosene sodium dihydrate, sodium carbonate and adipic acid)
featureFormerly known as ROProtect CR
formtablet
H10.2 cm (4 in.)
packagingpkg of 24 tablets
Quality Level300
shipped inambient
storage conditiondry at room temperature (Tightly closed. Do not store near acids)
This product has met the following criteria: